HomeCompareTOWN vs ABBV

TOWN vs ABBV: Dividend Comparison 2026

TOWN yields 3.15% · ABBV yields 3.06%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 TOWN wins by $23.6K in total portfolio value· pulled ahead in Year 9
10 years
TOWN
TOWN
● Live price
3.15%
Share price
$33.67
Annual div
$1.06
5Y div CAGR
43%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$126.0K
Annual income
$45,843.73
Full TOWN calculator →
ABBV
AbbVie Inc.
● Live price
3.06%
Share price
$217.44
Annual div
$6.65
5Y div CAGR
40.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$102.3K
Annual income
$24,771.77
Full ABBV calculator →

Portfolio growth — TOWN vs ABBV

📍 TOWN pulled ahead of the other in Year 9

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTOWNABBV
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TOWN + ABBV cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
TOWN pays
ABBV pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TOWN
Annual income on $10K today (after 15% tax)
$267.60/yr
After 10yr DRIP, annual income (after tax)
$38,967.17/yr
ABBV
Annual income on $10K today (after 15% tax)
$259.96/yr
After 10yr DRIP, annual income (after tax)
$21,056.00/yr
At 15% tax rate, TOWN beats the other by $17,911.17/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TOWN + ABBV for your $10,000?

TOWN: 50%ABBV: 50%
100% ABBV50/50100% TOWN
Portfolio after 10yr
$114.1K
Annual income
$35,307.74/yr
Blended yield
30.93%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ABBV right now

TOWN
Analyst Ratings
3
Buy
3
Hold
Consensus: Buy
Altman Z
-0.5
Piotroski
6/9
ABBV
Analyst Ratings
27
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$256.15
+17.8% upside vs current
Range: $223.00 — $299.00
Altman Z
2.0
Piotroski
8/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TOWN buys
0
ABBV buys
0
No recent congressional trades found for TOWN or ABBV in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTOWNABBV
Forward yield3.15%3.06%
Annual dividend / share$1.06$6.65
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR43%40.6%
Portfolio after 10y$126.0K$102.3K
Annual income after 10y$45,843.73$24,771.77
Total dividends collected$97.0K$61.0K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy

Year-by-year: TOWN vs ABBV ($10,000, DRIP)

YearTOWN PortfolioTOWN Income/yrABBV PortfolioABBV Income/yrGap
1$11,150$450.19$11,550$430.00$400.00ABBV
2$12,602$670.86$13,472$627.96$870.00ABBV
3$14,497$1,013.28$15,906$926.08$1.4KABBV
4$17,070$1,557.87$19,071$1,382.55$2.0KABBV
5$20,716$2,451.50$23,302$2,095.81$2.6KABBV
6$26,142$3,976.18$29,150$3,237.93$3.0KABBV
7$34,678$6,705.88$37,536$5,121.41$2.9KABBV
8$48,994$11,888.31$50,079$8,338.38$1.1KABBV
9← crossover$74,871$22,447.03$69,753$14,065.80+$5.1KTOWN
10$125,955$45,843.73$102,337$24,771.77+$23.6KTOWN

TOWN vs ABBV: Complete Analysis 2026

TOWNStock

TowneBank provides retail and commercial banking services for individuals, commercial enterprises, and professionals. The company operates through three segments: Banking, Realty, and Insurance. It accepts various deposits, including demand deposits, savings accounts, money rate savings, certificates of deposit, and individual retirement accounts. The company also offers secured and unsecured personal loans for financing automobiles, home improvements, education, and personal investments; commercial loans for working capital, business expansion, and equipment and machinery purchases; and mortgage loans, as well as real estate acquisition, development, and construction loans. In addition, it provides other services, such as safe deposit boxes, treasury management services, direct deposit of payroll and social security checks, and automatic drafts for various accounts, as well as online, mobile, and on-call banking services. Further, the company offers documentation services to accomplish tax deferral to investors; investment and asset management services; commercial mortgage brokerage services; and other financial services, such as financial, retirement, and estate planning services, as well as assistance on various investment options comprising alternative investments, annuities, margin accounts, convertible bonds, and pension and profit-sharing plans. Additionally, it provides residential real estate, relocation, property management, vacations rental, and title and settlement services; and originates residential mortgage loans. The company also offers life, property, casualty, and vehicle insurance services; and employee benefit programs, such as health, dental, vision, and disability insurance. It operates in Richmond, Virginia, the Greater Hampton Roads region in southeastern Virginia, northeastern North Carolina, Raleigh, Charlotte, Greensboro, and Greenville, North Carolina. TowneBank was incorporated in 1998 and is headquartered in Portsmouth, Virginia.

Full TOWN Calculator →

ABBVHealthcare

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

Full ABBV Calculator →
📬

Get this TOWN vs ABBV comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TOWN vs SCHDTOWN vs JEPITOWN vs OTOWN vs KOTOWN vs MAINTOWN vs JNJTOWN vs MRKTOWN vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.